Aya Obata-Onai

1.2k citations
5 papers · 993 indexed · 1 hit paper · h-index 5
Topics
Immunotherapy and Immune Responses (5 papers)T-cell and B-cell Immunology (5 papers)Immune Cell Function and Interaction (3 papers)
Partner nations
JapanGermany

In The Last Decade

Aya Obata-Onai

5 papers receiving 982 citations

Hit Papers

Identification of clonogenic common Flt3+M-CSFR+ plasmacy...20072026201320192007100200300400500

Peers

Aya Obata-Onai
Comparison fields: 5 of 60
  • Immunology 903
  • Molecular Biology 143
  • Oncology 114
  • Hematology 51
  • Epidemiology 45
Replace A M Kruisbeek with:
A M Kruisbeek United States
Ralph M. Steinman United States
G.C. Spagnoli Switzerland
Marcella Flores United States
Dick John Pang United Kingdom
Miriam A. Ossevoort Netherlands
Machiko Atsuta Japan
Sergiusz Markowicz Poland
Sally V. Watt Australia
Kenichi Takaku Japan
Aya Obata-Onai relative to A M Kruisbeek United States A M Kruisbeek's profile →
Citations per field
00.5×10×20×30×37×
A M Kruisbeek · 1×
Citations per year

Countries citing papers authored by Aya Obata-Onai

Since Specialization
Citations

This map shows the geographic impact of Aya Obata-Onai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aya Obata-Onai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aya Obata-Onai more than expected).

Fields of papers citing papers by Aya Obata-Onai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aya Obata-Onai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aya Obata-Onai. The network helps show where Aya Obata-Onai may publish in the future.

Co-authorship network of co-authors of Aya Obata-Onai

This figure shows the co-authorship network connecting the top 25 collaborators of Aya Obata-Onai. A scholar is included among the top collaborators of Aya Obata-Onai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aya Obata-Onai. Aya Obata-Onai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About Aya Obata-Onai

Aya Obata-Onai is a scholar working on Immunology, Infectious Diseases and Organic Chemistry, having authored 5 papers that have together received 993 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (903 citations), Hematology (51 citations) and Microbiology (27 citations). Aya Obata-Onai has collaborated with scholars based in Japan and Germany. Frequent co-authors include Nobuyuki Onai, Markus G. Manz, Michael Schmid, David Jarrossay, Toshiaki Ohteki, Dirk Baumjohann, Roxane Tussiwand, Antonio Lanzavecchia, Takemitsu Nagahata and Makoto Kurachi. Their work appears in journals such as The Journal of Experimental Medicine, Blood and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026